Medpace Holdings (MEDP) Tops Q4 EPS by 7c

Medpace Holdings (NASDAQ: MEDP) reported Q4 EPS of $1.32, $0.07 better than the analyst estimate of $1.25. Revenue for the quarter came in at $308.6 million versus the consensus estimate of $309.04 million.

GUIDANCE:

Medpace Holdings sees FY2022 EPS of $5.35-$5.67, versus the consensus of $5.49. Medpace Holdings sees FY2022 revenue of $1.4-1.46 billion, versus the consensus of $1.44 billion.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• SYNNEX Corp. (SNX) Tops Q2 EPS by 74c, Beats on Revenue; Offers Q3 Guidance
• AeroVironment (AVAV) Tops Q4 EPS by 36c